New Fabry Drug Report Drags Amicus Down

Boston, MA 02/19/2013 (wallstreetpr) – Amicus Therapeutics, Inc. (NASDAQ:FOLD) had been working on a drug called migalastat. This drug was being developed for the treatment of a rare genetic disorder named Fabry disease which is caused when body cells buildup a certain type of fat. This fat is highly detrimental to the health in that […]